Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

Lancet

Volumn 349, Issue 9069, 1996, Pages 1864-1867

  Veronesi, Umberto ^a   Paganelli, Giovanni ^a   Galimberti, Viviana ^a   Viale, Giuseppe ^a   Zurrida, Stefano ^a   Bedoni, Marilia ^a   Costa, Alberto ^a   De Cicco, Concetta ^a   Geraghty, James G ^a   Luini, Alberto ^a   Sacchini, Virgilio ^a   Veronesi, Paolo ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN SERUM ALBUMIN; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; EARLY DIAGNOSIS; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCINTIGRAPHY; SURGICAL TECHNIQUE;

EID: 0030604557     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)01004-0     Document Type: Article

References (20)

1. 1 Veronesi U, Rilke F, Luini A, et al. Distribution of axillary node metastases by level of invasion: an analysis of 539 cases. Cancer 1986; 59: 682-87.
2. 2 Veronesi U, Luini A, Galimberti V, et al. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990; 16: 127-33.
3. 3 Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152: 765-72.
4. 4 Consensus conference. Adjuvant chemotherapy for breast cancer. JAMA 1985; 254: 3461-63.
5. 5 Moffat F, Senofsky G, Davis K, et al. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 1992; 51: 8-13.
6. 6 Morton D, Wen D, Cochran A. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or "watch and wait". Surg Oncol Clin N Am 1992; 1: 247-59.
7. 7 Morton D, Wen D, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-99.
8. 8 Van der Veen H, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma-probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994; 81(12): 1769-70.
9. 9 Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401.
10. 10 Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-39.
11. 11 Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-22.
12. 12 WHO. Histological typing of breast tumours, 2nd edn, international histological classification of tumours no 2. Geneva: WHO, 1981.
13. 13 Rosen PP, Oberman HA. Tumors of the mammary gland. Washington DC: Armed Forces Institute of Pathology, 1993.
14. 14 Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: the value of histological grade in breast cancer. Histopathology 1991; 19: 403-10.
15. 15 Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
16. 16 Doglioni C, Dei Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996; 20: 1037-46.
17. 17 Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 1996; 62 (2): 75-77.
18. 18 Chilosi M, Lestani M, Pedron S, et al. A rapid immunostaining method for frozen sections. Biotechnic Histochem 1994; 69: 235-39.
19. 19 Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-81.
20. 20 Greco M, Agresti R, Raselli R, Giovanazzi R, Veronesi U. Axillary dissection can be avoided in selected breast cancer patients. Analysis of 401 cases. Anticancer Res 1996; 16: 3913-18.